Big Pharma delivered strong Q4 2025 results, with most companies beating revenue and EPS expectations and providing generally solid 2026 guidance. Eli Lilly solidified its leadership in obesity and ...
Amgen Inc. (NASDAQ:AMGN) is included among the 15 Best S&P 500 Dividend Stocks to Buy in 2026. On January 20, Bernstein ...
Amateur mathematicians are using artificial intelligence chatbots to solve long-standing problems, in a move that has taken professionals by surprise. While the problems in question aren’t the most ...
LIB Therapeutics secured a green light for its lipid-lowering PCSK9-blocking lerodalcibep in the US, for the treatment of adults with hypercholesterolemia. Lerodalcibep is the first adnectin-based ...
Amgen (NASDAQ: AMGN) today announced financial results for the fourth quarter and full year of 2025 versus the ...
The most dangerous part of AI might not be the fact that it hallucinates—making up its own version of the truth—but that it ceaselessly agrees with users’ version of the truth. This danger is creating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results